Skip Nav Destination
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma
Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children
Issue Archive
Table of Contents
BLOOD FLASHBACK
INSIDE BLOOD COMMENTARIES
PLENARY PAPER
PLATELETS AND THROMBOPOIESIS
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)
Sanjay Khandelwal,Grace M. Lee,C. Garren Hester,Mortimer Poncz,Steven E. McKenzie,Bruce S. Sachais,Lubica Rauova,Garnett Kelsoe,Douglas B. Cines,Michael Frank,Gowthami M. Arepally
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma
Clinical Trials & Observations
Alexandra Albertsson-Lindblad,Arne Kolstad,Anna Laurell,Riikka Räty,Kirsten Grønbæk,Jan Sundberg,Lone Bredo Pedersen,Elisabeth Ralfkiær,Marja-Liisa Karjalainen-Lindsberg,Christer Sundström,Mats Ehinger,Christian Geisler,Mats Jerkeman
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma
Clinical Trials & Observations
Torben Plesner,Hendrik-Tobias Arkenau,Peter Gimsing,Jakub Krejcik,Charlotte Lemech,Monique C. Minnema,Ulrik Lassen,Jacob P. Laubach,Antonio Palumbo,Steen Lisby,Linda Basse,Jianping Wang,A. Kate Sasser,Mary E. Guckert,Carla de Boer,Nushmia Z. Khokhar,Howard Yeh,Pamela L. Clemens,Tahamtan Ahmadi,Henk M. Lokhorst,Paul G. Richardson
HEMATOPOIESIS AND STEM CELLS
LYMPHOID NEOPLASIA
MYELOID NEOPLASIA
Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Michael Xiang,Haesook Kim,Vincent T. Ho,Sarah R. Walker,Michal Bar-Natan,Melodi Anahtar,Suhu Liu,Patricia A. Toniolo,Yasmin Kroll,Nichole Jones,Zachary T. Giaccone,Lisa N. Heppler,Darwin Q. Ye,Jason J. Marineau,Daniel Shaw,James E. Bradner,Traci Blonquist,Donna Neuberg,Claudio Hetz,Richard M. Stone,Robert J. Soiffer,David A. Frank
THROMBOSIS AND HEMOSTASIS
Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children
Clinical Trials & Observations
VASCULAR BIOLOGY
LETTERS TO BLOOD
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II
Roberta Russo,Immacolata Andolfo,Francesco Manna,Gianluca De Rosa,Luigia De Falco,Antonella Gambale,Mariasole Bruno,Alessandro Mattè,Paolo Ricchi,Domenico Girelli,Lucia De Franceschi,Achille Iolascon
BLOOD WORK
-
Cover Image
Cover Image
Targeting of the prosurvival protein MCL1 limits the growth of multiple myeloma cells (large pale cells with eccentric nuclei) allowing the recovery of normal hematopoiesis. See the article by Gong et al on page 1834.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals